Influence of adrenergic and cholinergic mediators on the equine jejunum in vitro

American Journal of Veterinary Research

Volumn 57, Issue 6, 1996, Pages 884-890

  Malone, E D ^a   Brown, D R ^a   Trent, A M ^a   Turner, T A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; ISOPRENALINE; NORADRENALIN; OXYMETAZOLINE; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; SALBUTAMOL; TETRODOTOXIN; VERAPAMIL; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HORSE; IN VITRO STUDY; JEJUNUM; NONHUMAN; SMOOTH MUSCLE CONTRACTION;

ACETYLCHOLINE; ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; ATROPINE; CALCIUM CHANNEL BLOCKERS; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HORSES; ISOPROTERENOL; JEJUNUM; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; OXYMETAZOLINE; PARASYMPATHETIC NERVOUS SYSTEM; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; QUINOXALINES; SYMPATHETIC NERVOUS SYSTEM; TETRODOTOXIN; VERAPAMIL; YOHIMBINE;

EID: 0029890911     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gerring EEL, Hunt JM. Pathophysiology of equine post-operative ileus: effect of adrenergic blockade, parasympathetic stimulation and metoclopramide in an experimental model. Equine Vet J 1986;18:249-255.
2. Adams SB. Recognition and management of ileus. Vet Clin North Am Equine Pract 1988;4:91-104.
3. Clark SE. Intestinal motility. In: White NA, ed. The equine acute abdomen. Philadelphia: Lea & Febiger, 1990;36-48.
4. Adams SB, Lamar CH, Masty J. Motility of the distal portion of the jejunum and pelvic flexure in ponies: effects of six drugs. Am J Vet Res 1984;45:795-799.
5. Hunt JM, Gerring EL. Effects of autonomic agonists on equine gastrointestinal electromechanical activity, in Proceedings. Equine Colic Res 2nd Symp 1986;210-213.
6. Ruckebusch Y, Roger T. Prokinetic effects of cisapride, naloxone, and parasympathetic stimulation at the equine ileo-caecocolonic junction. J Vet Pharmacol Ther 1988;11:322-329.
7. Livingston EH, Passaro EP. Postoperative ileus. Dig Dis Sci 1990;35:121-132.
8. Gillis RA, Souza JD, Hicks KA, et al. Inhibitory control of proximal colonic motility by the sympathetic nervous system. Am J Physiol 1987;253:G531-G539.
9. Thompson DG. Extrinsic autonomie control of human gastrointestinal transit. In: Kamm MA, Lennard-Jones JE, eds. Gastrointestinal transit: pathophysiology, and pharmacology. Philadelphia: Wrightson Biomedical Publishing Ltd, 1991;13-20.
10. 2-adrenoceptor-mediated responses in the pony. J Vet Pharmacol Ther 1987;10:310-318.
11. Stick JA, Chou CC, Derksen FJ, et al. Effects of xylazine on equine intestinal vascular resistance, motility, compliance, and oxygen consumption. Am J Vet Res 1987;48:198-203.
12. Merritt AM, Campbell-Thompson ML, Lowrey S. Effect of xylazine treatment on equine proximal gastrointestinal tract myoelectrical activity. Am J Vet Res 1989;50:945-949.
13. Lesler GD. Disorders of equine GI motility and the use of prokinetic drugs, in Proceedings. 12th Am Coll Vet Intern Med Forum 1994;603-606.
14. Guyton AC. General principles of gastrointestinal function - motility, nervous control, and blood circulation. In: Guyton AC, ed. Textbook of medical physiology. 8th ed. Philadelphia: WB Saunders Co, 1991;688-697.
15. Ruckebusch M, Grivel M-L, Fargeas M-J. Sur l'action paradoxale de l'adrenaline au niveau de l'intestin grele chex le cheval. Arch Int Pharmacodyn 1971;194:387-402.
16. Brown DR, Carraway RE, Parsons AM, et al. Neurotensin-related peptides inhibit spontaneous longitudinal contractions of porcine distal jejunum. Peptides 1990;11:713-718.
17. Daniel EE, Helmy-Elkholy A, Jager LP, et al. Neither a purine nor VIP is the mediator of inhibitory nerves of opossum oesophageal smooth muscle. J Physiol 1983;336:243-260.
18. Roberts MC, Argenzio A. Effects of amitraz, several opiate derivatives and anticholinergic agents on intestinal transit in ponies. Equine Vet J 1986;18:256-260.
19. MacHarg MA, Adams SB, Lamar CH, et al. Electromyographic, myomechanical, and intraluminal pressure changes associated with acute extraluminal obstruction of the jejunum in conscious ponies. Am J Vet Res 1986;47:7-11.
20. Bueno L, Fiorramonti J. Cerebral and spinal control of gastrointestinal motor functions. In: Kamm MA, Lennard-Jones JE, eds. Gastrointestinal transit: pathophysiology and pharmacology. Philadelphia: Wrightson Biomedical Publishing Ltd, 1991;3-11.
21. Read NW. Small intestinal motility physiology. In: Mc-Callum RW, Champion MC, eds. Gastrointestinal motility disorders. Baltimore: The Williams & Wilkins Co, 1990;23-36.
22. 2-adrenoceptor agonists in the brain. Acta Vet Scand 1986;82:35-46.
23. 2-adrenergic receptor antagonists. J Am Vet Med Assoc 1989;195:378-381.
24. O'Brien JD, Thompson DG, Day SJ, et al. Perturbation of upper gastrointestinal transit and antroduodenal motility by experimentally applied stress: the role of beta-adrenoreceptor mediated pathways. Gut 1989;30:1530-1539.
25. Davies JV. Normal intestinal motility. Vet Clin North Am Equine Pract 1989;5:271-281.
26. Sellers AF, Lowe JE, Rendano VT. Equine colonie motility: interactions among wall motion, propulsion, and fluid flow. Am J Vet Res 1984;45:357-360.
27. Davies JV, Gerring EL. Effect of spasmolytic analgesic drugs on the motility patterns of the equine small intestine. Res Vet Sci 1983;34:334-339.